Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Corrêa-Oliveira R, Martins-Filho OA. Reis AB, et al. Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):102-16. doi: 10.1016/j.vetimm.2006.02.001. Epub 2006 Apr 18. Vet Immunol Immunopathol. 2006. PMID: 16621021
Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs.
Giunchetti RC, Corrêa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Roatt BM, de Oliveira Aguiar-Soares RD, de Souza JV, das Dores Moreira N, Malaquias LC, Mota e Castro LL, de Lana M, Reis AB. Giunchetti RC, et al. Vaccine. 2007 Nov 1;25(44):7674-86. doi: 10.1016/j.vaccine.2007.08.009. Epub 2007 Aug 24. Vaccine. 2007. PMID: 17913311 Free PMC article.
Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis.
Araújo MS, de Andrade RA, Vianna LR, Mayrink W, Reis AB, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Mello MN, Martins-Filho OA. Araújo MS, et al. Vaccine. 2008 Apr 24;26(18):2211-24. doi: 10.1016/j.vaccine.2008.02.044. Epub 2008 Mar 18. Vaccine. 2008. PMID: 18395948
439 results